Olink Holding AB (publ) Q2 2023 Earnings Report

Olink Holding AB (publ) EPS Results

• Actual EPS: -$0.07
• Consensus EPS: -$0.09
• Beat/Miss: Beat by +$0.02
• One Year Ago EPS: N/A

Olink Holding AB (publ) Revenue Results

• Actual Revenue: $29.44 million
• Expected Revenue: $33.49 million
• Beat/Miss: Missed by -$4.05 million
• YoY Revenue Growth: N/A

Olink Holding AB (publ) Announcement Details

• Quarter: Q2 2023
• Date: 8/9/2023
• Time: N/A

Olink Holding AB (publ) (NASDAQ:OLK) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.